Janghorbani Mohsen, Amini Masoud
Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran; Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Diabetes Res Clin Pract. 2015 Jun;108(3):414-22. doi: 10.1016/j.diabres.2015.03.002. Epub 2015 Mar 13.
To estimate the progression rates from normal glucose tolerance (NGT), isolated impaired glucose tolerance (IGT), isolated impaired fasting glucose (IFG) and combined IFG/IGT to type 2 diabetes (T2D) in a high risk population with and without hypertension (HTN) in Isfahan, Iran.
During a mean (SD) follow-up period of 6.8 (1.7) years, 1489 non-diabetic first-degree relatives of patients with T2D with or without HTN were followed for the occurrence of T2D. At baseline and through follow-ups, participants underwent a standard 75g 2-h oral glucose tolerance test. Blood pressure was measured by standardised protocols and HTN was defined according to the criteria of the JNC7.
The progression rate (95% confidence interval) from NGT, isolated IFG, isolated IGT, and combined IFG/IGT to T2D was 10.0 (4.3, 19.6), 21.7 (9.5, 42.3), 28.2 (12.3, 54.7) and 64.7 (41.0, 96.4) per 1000 person-years in participants with HTN and 3.1 (1.5, 4.7), 16.3 (10.3, 24.2), 25.9 (17.0, 37.7) and 57.9 (46.1, 71.7) per 1000 person-years in participants without HTN based on 10,134 person-years of follow-up. Compared with individuals with NGT and without HTN, individuals with NGT and HTN, isolated IFG, isolated IGT, and combined IFG/IGT with or without HTN at baseline were more likely to progress to T2D. Compared with participants without HTN, individuals with concomitant HTN were not significantly more likely to progress to T2D.
Compared with individuals without HTN, the presence of NGT, isolated IFG, isolated IGT, and combined IFG/IGT with concomitant HTN was not associated with higher likelihood of progression to T2D in high-risk individuals in Iran.
评估伊朗伊斯法罕有高血压(HTN)和无高血压的高危人群中,从正常糖耐量(NGT)、单纯糖耐量受损(IGT)、单纯空腹血糖受损(IFG)以及IFG/IGT合并存在状态进展为2型糖尿病(T2D)的发生率。
在平均(标准差)6.8(1.7)年的随访期内,对1489例患有或未患有高血压的T2D患者的非糖尿病一级亲属进行T2D发病情况随访。在基线期及随访期间,参与者接受标准的75克2小时口服糖耐量试验。血压通过标准化方案测量,高血压根据美国国家联合委员会第7版(JNC7)标准定义。
基于10134人年的随访,在患有高血压的参与者中,从NGT、单纯IFG、单纯IGT以及IFG/IGT合并存在状态进展为T2D的发生率(95%置信区间)分别为每1000人年10.0(4.3,19.6)、21.7(9.5,42.3)、28.2(12.3,54.7)和64.7(41.0,96.4);在未患有高血压的参与者中,相应发生率分别为每1000人年3.1(1.5,4.7)、16.3(10.3,24.2)、25.9(17.0,37.7)和57.9(46.1,71.7)。与基线时NGT且无高血压的个体相比,基线时NGT且有高血压、单纯IFG、单纯IGT以及IFG/IGT合并存在状态且有或无高血压的个体进展为T2D的可能性更大。与未患有高血压的参与者相比,同时患有高血压的个体进展为T2D的可能性并无显著增加。
在伊朗的高危个体中,与无高血压的个体相比,存在NGT、单纯IFG、单纯IGT以及IFG/IGT合并存在状态且伴有高血压与进展为T2D的较高可能性无关。